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ABSTRACT 
Objective: Pharmacognostical study along with the development of a quantitative HPTLC method for Crinum latifolium and evaluation of its 
traditional claims. 
Methods: Quantification of three marker compounds oleanolic acid, linoleic acid, and lupeol was done through HPTLC. In vitro antioxidant activity 
was determined by six different models, namely total phenolic and total flavonoid content, DPPH radical scavenging assay, ferric reducing power, 
antioxidant capacity and hydroxyl radical scavenging assay. In vitro antidiabetic activity was evaluated by α-amylase inhibition assay based on 
starch iodine and DNS method. 
Results: The content of oleanolic acid, linoleic acid, and lupeol were found to be higher in aerial parts like 0.015%, 0.048%, and 0.028% 
respectively, while in root extract 0.006%, 0.027% and 0.025% respectively on a dry weight basis. Free radical scavenging activity was done by 
DPPH assay, showing the IC50 value of 410±1.105 µg/ml in roots and 441.95±1.788 in aerial parts. In vitro antidiabetic potential of both the parts 
were assessed by starch iodine color assay and DNS method of alpha-amylase inhibition model. In 3,5 DNS assay, IC50 of extract from aerial parts 
was 282.21±2.151µg/ml whereas in root extract it was 193.33±2.45µg/ml. Iodine-starch assay of C. latifolium (aerial part) shown the IC50 value of 
340.81±0.49 µg/ml and C. latifolium (root) of 74.64±1.28 µg/ml. 
Conclusion: The results indicate that the aerial parts of the plant possess more antidiabetic potential in comparison to the root. Thus, the aerial part 
can be used to get better results as a drug and roots can be used as an alternative. 
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The Indian traditional medicine system is one of the oldest systems of 
conventional healing. Some of this vast indigenous knowledge is 
documented in scriptures while a voluminous amount of knowledge is 
not documented. Such information is localized to some ethnic or rural 
communities and transferred from one generation to the other only 
via verbal means. The documented medicine systems include 
Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homeopathy; 
abbreviated as AYUSH.  
With the recent upsurge of the idea of ‘evidence-based validated 
medicine’, scientific evaluation of claims mentioned in ancient texts 
is now a thrust area of research. This approach has contributed 
significantly to the scientific validation of the traditional claims. 
Amaryllidaceae is a family of perennial, herbaceous, and bulbous 
plants known for their therapeutic potential in folklore medicine. The 
genus Crinum is widely used in folk medicine and a lot of scientific 
investigation has been made to explore its pharmacological potential 
[1]. However, from the literature survey, it was evident that studies 
related to pharmacognosy of Crinum latifolium are relatively less 
prevalent. The studies of pharmacognostic parameters are equally 
important to establish the authenticity of a plant as an herbal drug. 
This formed the rationale behind the present study.  
Crinum, commonly known as “Sudarshan” in Hindi and “Madhuparnika” 
in Sanskrit, is used as a tonic, treatment of allergic disorders, 
inflammation and tumor diseases. The leaf juice is applied topically to 
skin diseases and on piles to reduce pain and swelling [2]. It is also used 
as an analgesic, immune stimulating, antineoplastic, antiviral and 
antimicrobial, as a remedy for blood pressure, rheumatism and in 
weakness [3]. C. latifolium is used in many Ayurvedic formulations such 
as Mahasudarshan curna which is traditionally used as antiviral, 
antimalarial and antipyretic [4], thus have huge industrial potential. The 
species is reach in glucan A and B, phenylalanine, L-leucin, DL-valin, L-
arginin monohydrochloride, latisolin, latisodin, ambellin, 11-o-
acetylambellin, 11-o acetyl 1, 2-ß epoxyambellin, crinafolin, crinafolidin, 
lycorin, epilycorin, epipancrassidin, 9-o-demethylhomolycorin, lycorin-1, 
o-glucoside, pratorin (hippadin), pratorinin, pratorimin, pratosin, 
beladin, latindin and latifin [5-6]. 
To the best of our knowledge, there are few reports available which 
document the pharmacognostic and pharmacological aspects of C. 
latifolium. Therefore, anatomical descriptors for the plant and a 
simple, rapid and reproducible HPTLC method for detection and 
quantification of major compounds such as lupeol, linoleic acid, and 
oleanolic acid were developed. Further, antioxidant and antidiabetic 
potential of the root and aerial parts of the C. latifolium was studied 
to evaluate the comparative activity of both the parts. 
The objective of this study was to enumerate the pharmacognostic 
as well as biological activities of root and aerial parts of C. latifolium. 
MATERIALS AND METHODS 
Plant material  
Whole plant (aerial part along with roots) of Crinum latifolium (fig. 
1) was collected in the month of September 2014 from Chitrakoot, 
Madhya Pradesh (India). The sample was authenticated by Dr. 
Sharad Srivastava, Scientist; CSIR-National Botanical Research 
Institute, Lucknow and voucher specimens were deposited in 
institute’s herbarium (LWG no. 262567). Collected sample was 
washed, shade dried and powdered for further studies. 
Chemicals and reagents 
Ascorbic acid (>99% w/w), gallic acid (>99% w/w), lupeol (>94% w/w), 
linoleic acid (>99% w/w), oleanolic acid (>99% w/w), 1-1-diphenyl-2-
picrylhydrazyl (DPPH), α-amylase and 3, 5-Dinitrosalicylic acid was 
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purchased from Sigma-Aldrich. Other solvents and chemicals (A. R 
grade) viz. starch soluble, iodine, aluminum chloride, sodium carbonate, 
Folin’s reagent, methanol, ethyl acetate, toluene, formic acid were 
procured from SD Fine Chemicals, Mumbai, India. 
Anatomical studies 
The freshly collected plant material was preserved in 70% ethanolic 
solution for anatomical studies. The anatomical studies were 
performed as per standard method [7]. Freehand sectioning was 
done to obtain thin sections so that cellular details are clearly 
visible. Sections were stained first with safranin and then with fast 
green to stain the secondary anatomical structures. The stained 
sections were mounted with glycerin on the glass slide and then 
observed under a light microscope. Photomicrographs were taken 
with Olympus, model CX31digital microscope at a magnification of 
10X for the ocular lens and 10X for the objective lens. 
Preparation of plant extracts 
The plant material was manually screened for any impurities and dried 
in shade, followed by drying in a hot air oven at 40˚C and ground 
(electric grinder) to a fine powder (40 mesh). The powdered sample, 5 
gm each of aerial part (Ar.) and root (Rt.) were separately treated with 
petroleum ether for removal of fatty impurity and then subjected to 
extraction in methanol. Samples were continuously stirred for 6 h, 
followed by standing time of 18 h at room temperature and then filtered 
(Whatman No. 1 filter paper). The extraction process was repeated till 
complete extraction and the pooled extract was concentrated under 
vacuum in a rotatory evaporator (Buchi rotavapor, Switzerland) under a 
standard condition of temperature and pressure. The extract was finally 
freeze-dried and stored at 4 °C for further use. 
High performance thin layer chromatography 
Preparation of working solutions 
The working solution of standards viz. lupeol, linoleic acid and 
oleanolic acid (1 mg/ml) and plant samples (10 mg/ml) were freshly 
prepared with methanol. For calibration, a stock solution of 1 mg/ml 
each of lupeol, linoleic acid and oleanolic acid were diluted in the 
same solvent to obtain three working solutions in a concentration 
ranging from 2-6 µg/ml. The solutions were filtered through a 0.45 
µm Millipore membrane filter (Pall, USA) before application. 
HPTLC conditions 
High-performance thin layer chromatography was used for separation of 
the components present in the extract, both quantitatively as well 
qualitatively. For quantitative analysis about 10 µl sample was applied 
using 100 µl sample syringe (Hamilton, Switzerland) on pre-coated 
plates with silica gel 60F254 of 0.2 mm thickness as 6 mm-wide bands 
positioned 10 mm from the bottom and 15 mm from side of the plate, 
using CAMAG Linomat V automated TLC applicator with nitrogen flow 
providing a delivery speed of 150 ml/s from application syringe. TLC 
plate developed in a CAMAG twin trough glass chamber which was pre-
saturated with mobile phase toluene: ethyl acetate: formic acid (7: 2.5: 
0.5 v/v). After the development of the plate, it was dried and then 
derivatized with anisaldehyde-sulphuric acid and scanned at 580 nm 
with a TLC scanner (winCATS 1.3.2, CAMAG) [8]. 
Pharmacological studies 
In vitro antioxidant activity 
Total flavonoid and phenolic content were estimated [9] and, 
expressed in terms of mg/g of QE (Quercetin Equivalent) and mg/g 
GAE (Gallic Acid Equivalent) based on the calibration curve of 
standard(s) Quercetin and Gallic acid respectively. The radical 
scavenging potential was analyzed via DPPH radical scavenging 
assay [10, 11], ferric reducing power [12], antioxidant capacity [13] 
and hydroxyl radical scavenging [14]. 
In vitro antidiabetic activity (Alpha amylase inhibition assay)  
Starch-iodine colour assay  
The assay was carried out with slight modification based on the 
starch-iodine test [15]. Methanol extract (500 μL) of varying 
concentrations were added to 500 μL of 0.02M sodium phosphate 
buffer (pH 6.9 containing 6 mmol sodium chloride) containing 0.04 
units of α-amylase solution and were incubated at 37 °C for 10 min, 
then 500 μL soluble starch (1% w/v) was added to each reaction well 
and again incubated at 37 °C for 15 min 1 M HCl (20 μL) was added to 
stop the enzymatic reaction, followed by the addition of 100 μl of 
iodine reagent (5 mmol I2 and 5 mmol KI). The colour change was 
noted and the absorbance was read at 620 nm on a microplate reader. 
The control reaction representing 100% enzyme activity did not 
contain any plant extract to eliminate the absorbance produced by 
plant extract; appropriate extract controls without the enzyme were 
also included. Inhibition of enzyme activity was calculated as:  
( )[ ] 100(%) ×÷−= CSCInhibition  
Where S is the absorbance of the sample and C is the absorbance of 
control (no extract). 
3, 5-Dinitrosalicylic acid (DNS) method  
The inhibition assay was performed using DNS method [16]. Methanol 
extract (500 μl) of varied concentrations were added to 500 μl of 0.02 
M sodium phosphate buffer (pH 6.9 containing 6 mmol sodium 
chloride) containing 0.04 units of α-amylase solution and were 
incubated at 37 °C for 10 min, followed by addition of 500 μl of a 1% 
starch solution (0.02 M sodium phosphate buffer, pH 6.9) in all the test 
tubes. The reaction was stopped with 1.0 ml of 3, 5 DNS reagent. The 
test tubes were then incubated in a boiling water bath for 5 min and 
cooled to room temperature. The reaction mixture was then diluted 
after adding 10 ml distilled water and absorbance was measured at 
540 nm. The control sample was also prepared accordingly without 
any plant extract and were compared with the test samples containing 
various concentrations of the plant extracts. The results were 
expressed as % inhibition calculated using the formula. 
( )[ ] 100(%) ×÷−= CSCInhibition  
where S is the absorbance of the sample and C is the absorbance of 
control (no extract) 
Statistical analysis 
Results were expressed as mean±SD Linear regressions analysis was 
carried out for standards to calculate total phenolic and flavonoid 
content. IC50 values were obtained by graph pad prism 5 software. 
One-way ANOVA followed by student’s t test (p<0.01) was used to 
find the significance of in vitro antidiabetic and antioxidant assays.  
 
 
Fig. 1: Crinum latifolium L. 
 
RESULTS AND DISCUSSION 
Microscopy 
C. latifolium was studied anatomically to understand the cellular 
details. Transverse section of the root (fig. 2) shows that the outline 
is irregularly circular. The epidermis is made up of hexagonal cells 
followed by multilayered sclerenchymatous cells containing 
exodermis which is lignified. Cortex is multilayered, cells polygonal 
in shape. Below the cortex, there is endodermis followed by 
pericycle. Vascular bundles are arranged in single radii which is 
exarch and polyarch condition. Treachery element is present in the 
form of an annular ring. Centrally located pith is present.  
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The T. S. of the leaf (fig. 3) reveals the presence of single layered 
epidermis on both upper and lower surfaces followed by a waxy 
cuticular layer. Cells are more or less circular in shape, but slightly 
columnar on the adaxial surface of the mid rib region. Stomata are 
normal with no outer and inner stomatal edges. Mesophyll cells 
distinguished into two parts, the upper and the lower mesophyll; 
upper mesophyll (palisade) is single layered, cells thin-walled 
columnar in shape, arranged with no intercellular spaces, but with 
numerous chloroplast; lower mesophyll cells, moderately 
chlorophyllous, thin-walled, iso-diametric shape and spongy in 
nature. Concentric vascular bundle of amphicribal type, phloem 
surrounds the xylem, arranged along the width of the leaf blade. 
 
 
Fig. 2: T. S. of Crinum latifolium L. Root A–(10X), B–(40X), C–(40X), D-(40X) Abbreviations: epi-epiblema, ex-exodermis, c-cortex, en-
endodermis, vb-vascular bundle, ph-phloem, x-xylem, p-pith, te-tracheiry element, ln-lignin 
 
 
Fig. 3: T. S. of Crinum latifolium. L, Leaves E–(10X), F–(40X), G–(10X), H-(40X) Abbreviations: cu–cuticle, ep–epidermis, pm–palisade 
mesophyll, sm–spongy mesophyll, p–phloem, mx–metaxylem, px–protoxylem, vb–vascular bundle, st–stomata 
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HPTLC quantification of marker compounds 
HPTLC method was developed for the quantification of targeted 
marker compounds oleanolic, linoleic acid and lupeol in C. latifolium. 
The extractive yield of C. latifolium (Rt.) and C. latifolium (Ar.) was 
31.0% and 24.0% respectively. TLC images were captured at the 
visible light after derivatization (fig. 4). The densitometric scan 
shows the different peaks of the marker compounds in the root (fig. 
5) as well as aerial part (fig. 6) samples. Various solvent systems 
have been tried varying ratio and polarity of constituent solvents of 
the mobile phase. The mobile phase consisting of toluene: ethyl 
acetate: formic acid (7: 2.5: 0.5, v/v/v) was optimized for 
quantitative study. Saturation time of the TLC chamber in the mobile 
phase was optimized to 20 min for a good resolution of the tested 
markers and the total run time was 30 min at room temperature 
(27±2 °C). The purity of the bands in the samples was confirmed by 
comparing band spectra of samples with the corresponding band 
spectra of standards at the start, middle and end position of the 
bands (fig. 7). Three dilutions of standards were used in the 
concentration range of 2 to 6 µg/ml and calibration parameters 
were established (table 1). The maximum concentration of oleanolic 
acid, linoleic acid and lupeol were found in aerial part i.e., 0.015%, 
0.048%, and 0.028% respectively on a dry weight basis, while the 
root extract contains 0.006%, 0.027%, and 0.025% respectively on a 
dry weight basis (table 2). Hens developed HPTLC method was 
found to be simple, accurate, precise and convenient for rapid 
screening of active constituents present in the methanolic extract of 
C. latifolium and can be used for routine analysis and quality control 




Fig. 4: HPTLC fig. printing of Crinum latifolium L., Abbreviation: S1, S2, S3–oleanolic acid; S4, S5, S6–linolic acid; S7, S8, S9-lupeol; 1-Crinum 
latifolium (Root), 2-Crinum latifolium (aerial part) 
 
 
Fig. 5: HPTLC chromatogram of Crinum latifolium (root) 
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Fig. 6: HPTLC chromatogram of Crinum Latifolium (Aerial part) 
 
 
Fig. 7: Purity spectra of (A) oleanolic acid, (B) linoleic acid and (C) lupeol 
 
Table 1: Calibration parameters of marker compounds* 
Parameters Oleanolic acids Linoleic acid Lupeol 
Linearity range (µg/ml) 2-6 2-6 2-6 
Rf 0.51 0.75 0.61 
Regression coefficient 0.9654 0.982 0.9869 
Average 11401.1 8682.55 10710.05 
Standard deviation 2948.77 2694.64 3035.18 
Standard error 775.67 511.36 492.18 
Slop 1448.66 1335.13 1507.58 
LOD (μg ml−1) 6.72 6.66 6.64 
LOQ (μg ml−1) 20.35 2018 20.13 
*mean±SD n=3 
 
Table 2: HPTLC quantification of marker compound in C. latifolium L 
Marker compound C. latifolium (Rt.)* C. latifolium (Ar.)* 
Oleanolic acid 0.006±0.0025 0.015±0.0026 
Linoleic acid 0.0276±0.0012 0.0483±0.0014 
Lupeol 0.0256±0.003 0.0287±0.0021 
 *mean±SD, n=3; Values on % dry weight basis  
 
In vitro antioxidant activity 
Polyphenolic compounds are mainly responsible for antioxidant 
potential of the plants [17]. To assess the antioxidant potential of the 
plant six models (total phenolic content, total flavonoid content, 
DPPH radical scavenging assay, Ferric reducing power, Total 
antioxidant capacity and 2-Deoxyribose assay) were used. Total 
phenolic content in the aerial and root extract was found to be 
2.32±0.12 mg/g GAE and 3.59±0.25 mg/g GAE respectively while the 
flavonoid content was reported to be 0.75±0.03 mg/g QE and 
0.916±0.011 mg/g QE respectively (table 3). 
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Table 3: Total phenolic and flavonoid content 
 Sample Total phenolic content (mg/g)*GAE Total flavonoid content (mg/g)*QE 
y = 186.34x-0.0119 R² = 0.9906  y = 106.7x-0.2215 R² = 0.9922  
C. latifolium (Rt.) 3.59±0.25 0.916±0.011 
C. latifolium (Ar.) 2.32±0.125 0.75±0.03 
(*mean±SD, n=3) 
 
Reducing power activity (fig. 8) of aerial and root extract increase 
linearly with increase in concentration, with a regression coefficient 
(r2) of 0.9562 and 0.9532 respectively which is in correlation to the 
standards i.e. ascorbic acid (0.998), quercetin (0.997) and rutin 
(0.998). C. latifolium showed moderate antioxidant activity against the 
values of standards (Gallic acid, ascorbic acid, and quercetin) used. 
Antioxidant activity of both extracts of the C. latifolium was found to 
increase with the increasing concentration. In DPPH radical 
scavenging activity, the IC50 value of C. latifolium (Rt.) was 410±1.105 
µg/ml and C. latifolium (Ar.) 441.95±1.788 µg/ml. In hydroxyl radical 
scavenging, the IC50 value of C. latifolium (Rt.) was 50.64±0.869 µg/ml 
and C. latifolium (Ar.) was 158.75±1.394 µg/ml (table 4). 
 
Table 4: IC50 value for in vitro anti oxidant activity 
S. No. Plant sample IC50 values (µg/ml)* 
DPPH assay 2-deoxy ribose 
1. C. latifolium (Rt.) 410±1.105 158.75±1.394 




Fig. 8: Ferric reducing power of C. latifolium root and aerial part 
 
In vitro antidiabetic activity 
In vitro antidiabetic potential of both the plant parts were assessed 
by starch iodine color assay and 3, 5 DNS method of alpha-amylase 
inhibition model. The starch-Iodine assay reveals that activity 
increases linearly with concentration i.e. 0.1-0.5 mg/ml of tested 
plant extract. In 3, 5 DNS assay, IC50 value of root extract and aerial 
extract was 193.33±2.45µg/ml and 282.21±2.151µg/ml respectively 
whereas in iodine starch assay the values were reported to be 
74.64±1.28 µg/ml and 340.81±0.49 mg/ml respectively (table 5) 
whilst acarbose exhibit IC50 at<25 µg/ml. Results of α-amylase 
inhibition by DNS shows that an increase in the concentration of 
inhibitors, degradation of starch reduces and thus indicating the 
inhibition of enzyme activity. From the above study, it was observed 
that the methanolic extract of C. latifolium has potential antidiabetic 
property when compared to the standard drug.  
Antioxidant and antidiabetic potential of C. latifolium was studied to 
assess the comparative potential of both the parts. In a nutshell, we 
concluded that bioactive compounds such as lupeol, linoleic acid, 
and an oleanolic acid, having well said antidiabetic potential, are 
present in sufficient quantities in both parts of the plant with 
promising antioxidant action. From the above study, it is observed 
that the quantified major bioactive compounds are mainly 
responsible for the biological potential of the C. latifolium. 
 
Table 5: IC50 value for in vitro antidiabetic assay 
S. No. Plant sample IC50 values (µg/ml)* 
DNS method Starch iodine method 
1. C. latifolium (Rt.) 193.33±2.45 282.21±2.151 
2. C. latifolium (Ar.) 74.64±1.28  340.81±0.49 
 (*mean±SD, n=3) 
 
CONCLUSION 
The present study showed promising anti-diabetic potential in both 
parts of the plant along with the good antioxidant activity. 
Therefore, it is necessary to find out the lead compound, which is 
responsible for the potential of the medicinal plant. Hence, the 
proposed phytochemical analysis, HPTLC fingerprint, and biological 
potential can be used as a supportive aid in the quality evaluation 
and standardization of the raw material used in industries. 
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